Figure 12From: What do we know about communicating risk? A brief review and suggestion for contextualising serious, but rare, risk, and the example of cox-2 selective and non-selective NSAIDsAdditional risk of dying from an upper gastrointestinal bleed or cardiovascular event with rofecoxib. GI, gastrointestinal.Back to article page
